Testing effectiveness (Phase 2)Study completedNCT04188639What this trial is testingEmicizumab in Acquired Hemophilia AWho this might be right forHemophilia A, Acquired GWT-TUD GmbH 47
Early research (Phase 1)Study completedNCT01561417What this trial is testingBioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male SubjectsWho this might be right forAcquired Bleeding DisorderAcquired HaemophiliaCongenital Bleeding Disorder+5 more Novo Nordisk A/S 28
Large-scale testing (Phase 3)Ended earlyNCT00306670What this trial is testingTrial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia AWho this might be right forHemophilia A Georgetown University 2
Not applicableStudy completedNCT01285089What this trial is testingObservational Study on the Use of NovoSeven® for Haemostatic Treatment of Bleeding Episodes in Patients With Acquired HaemophiliaWho this might be right forAcquired Bleeding DisorderAcquired Haemophilia Novo Nordisk A/S 21
Not applicableUnknownNCT01856751What this trial is testingUse of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIaWho this might be right forHaemophilia Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus 80
Not applicableNo Longer AvailableNCT01968655What this trial is testingExpanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodiesWho this might be right forAcquired Hemophilia A Baxalta now part of Shire